Balyasny Asset Management LLC Solid Biosciences Inc. Transaction History

Balyasny Asset Management LLC

  • $54.9 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.51 - $7.56 $9,247 - $137,085
18,133 Added 156.35%
29,731 $14,000
Q2 2022

Aug 15, 2022
BUY
$0.43 - $1.24 $4,987 - $14,381
11,598 New
11,598 $7,000
Q3 2018

Nov 14, 2018
SELL
$36.35 - $51.7 $4.37 Million - $6.22 Million
-120,342 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$7.33 - $43.15 $882,106 - $5.19 Million
120,342 New
120,342 $4.29 Million

Others Institutions Holding SLDB

# of Institutions
2
Shares Held
97
Call Options Held
0
Put Options Held
0
View Full List

About Solid Biosciences Inc.

SLDB Quotes by TradingView
  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $53.2M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email